Nucleoside Transport as a Potential Target for Chemotherapy in Malaria

E-ISSN： 1873-4286|13|6|569-580

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.6, 2007-02, pp. : 569-580

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New Malaria Chemotherapy Developed by Utilization of a Unique Parasite Transport System

Current Pharmaceutical Design, Vol. 9, Iss. 11, 2003-04 ,pp. : 867-877

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Rational Drug Design Strategies with Potential to Revolutionize Malaria Chemotherapy

Current Medicinal Chemistry, Vol. 18, Iss. 1, 2011-01 ,pp. : 113-143

Bentham Science Publishers

Access to resources Recommend Favorite

Nuclear Factor Kappa B: A Potential Target for Anti-HIV Chemotherapy

Current Medicinal Chemistry, Vol. 10, Iss. 16, 2003-08 ,pp. : 1603-1615

Bentham Science Publishers

Access to resources Recommend Favorite

Choline Analogues in Malaria Chemotherapy

Current Pharmaceutical Design, Vol. 18, Iss. 24, 2012-01 ,pp. : 3454-3466

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Nucleoside Phosphorylase: A Potential Target for the Development of Drugs to Treat T-Cell- and Apicomplexan Parasite-Mediated Diseases

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 413-422

Bentham Science Publishers

Access to resources Recommend Favorite